E Hägg

2.4k total citations
38 papers, 1.8k citations indexed

About

E Hägg is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery. According to data from OpenAlex, E Hägg has authored 38 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in E Hägg's work include Acute Ischemic Stroke Management (8 papers), Diabetes and associated disorders (5 papers) and Neurological Disorders and Treatments (5 papers). E Hägg is often cited by papers focused on Acute Ischemic Stroke Management (8 papers), Diabetes and associated disorders (5 papers) and Neurological Disorders and Treatments (5 papers). E Hägg collaborates with scholars based in Sweden, United States and United Kingdom. E Hägg's co-authors include Kjell Asplund, Folke Lithner, Bo Carlberg, Tommy Olsson, T Strand, Sigbritt Rasmuson, P O Wester, Sven‐Erik Eriksson, F. Anders Karlsson and Ingela Wiklund and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Stroke and Diabetologia.

In The Last Decade

E Hägg

37 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Hägg Sweden 16 739 611 366 283 252 38 1.8k
Chongke Zhong China 26 292 0.4× 777 1.3× 298 0.8× 307 1.1× 201 0.8× 159 2.2k
Kwang‐Yeol Park South Korea 26 188 0.3× 860 1.4× 442 1.2× 589 2.1× 252 1.0× 125 2.3k
Robert P.J. Michels Netherlands 19 520 0.7× 109 0.2× 96 0.3× 115 0.4× 178 0.7× 31 1.9k
Louis Potier France 22 660 0.9× 185 0.3× 93 0.3× 350 1.2× 135 0.5× 79 1.7k
T. M. Greenaway Australia 18 404 0.5× 239 0.4× 133 0.4× 91 0.3× 324 1.3× 40 1.3k
Konstantinos Manolopoulos United Kingdom 23 527 0.7× 500 0.8× 62 0.2× 60 0.2× 808 3.2× 48 2.1k
Tomris Erbaş Türkiye 25 1.1k 1.5× 268 0.4× 241 0.7× 136 0.5× 581 2.3× 106 2.6k
Ophir Avizohar Israel 12 212 0.3× 459 0.8× 68 0.2× 126 0.4× 257 1.0× 17 960
V. Cacciatori Italy 20 882 1.2× 444 0.7× 53 0.1× 58 0.2× 520 2.1× 36 2.0k
Eliza B. Geer United States 24 1.5k 2.1× 486 0.8× 83 0.2× 64 0.2× 558 2.2× 83 2.7k

Countries citing papers authored by E Hägg

Since Specialization
Citations

This map shows the geographic impact of E Hägg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Hägg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Hägg more than expected).

Fields of papers citing papers by E Hägg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Hägg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Hägg. The network helps show where E Hägg may publish in the future.

Co-authorship network of co-authors of E Hägg

This figure shows the co-authorship network connecting the top 25 collaborators of E Hägg. A scholar is included among the top collaborators of E Hägg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Hägg. E Hägg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rolandsson, Olov, E Hägg, Marta Janer, et al.. (2003). High GAD65 autoantibody levels in nondiabetic adults are associated with HLA but not with CTLA‐4 or INS VNTR. Journal of Internal Medicine. 253(4). 447–453. 11 indexed citations
2.
Rolandsson, Olov, E Hägg, Mikael Nilsson, et al.. (2001). Prediction of diabetes with body mass index, oral glucose tolerance test and islet cell autoantibodies in a regional population. Journal of Internal Medicine. 249(4). 279–288. 35 indexed citations
3.
Hägg, E, et al.. (1999). Magnesium therapy in type 1 diabetes. A double blind study concerning the effects on kidney function and serum lipid levels.. PubMed. 12(2). 123–30. 8 indexed citations
4.
Rolandsson, Olov, E Hägg, Christiane S. Hampe, et al.. (1999). Glutamate decarboxylase (GAD65) and tyrosine phosphatase-like protein (IA-2) autoantibodies index in a regional population is related to glucose intolerance and body mass index. Diabetologia. 42(5). 555–559. 48 indexed citations
5.
Thorén, M., Margareta Bramnert, Agneta Hilding, et al.. (1998). Elderly patients with pituitary insufficiency benefit from growth hormone replacement therapy. Growth Hormone & IGF Research. 8(4). 347–347. 3 indexed citations
6.
Rasmuson, Sigbritt, Tommy Olsson, & E Hägg. (1996). A low dose ACTH test to assess the function of the hypothalamic–pituitary–adrenal axis. Clinical Endocrinology. 44(2). 151–156. 195 indexed citations
7.
Burman, Pia, Jan‐Erik Broman, Jerker Hetta, et al.. (1995). Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial.. The Journal of Clinical Endocrinology & Metabolism. 80(12). 3585–3590. 232 indexed citations
8.
Holmberg, Björn, E Hägg, M. Duchek, & Lars Hagenfeldt. (1992). Screening of patients with hereditary spastic paraparesis and Addison's disease for adrenoleukodystrophy/adrenomyeloneuropathy. Acta Neurologica Scandinavica. 85(2). 147–149. 4 indexed citations
9.
Olsson, Tommy, Matti Viitanen, E Hägg, et al.. (1991). Catecholamine excretion in old age. Aging Clinical and Experimental Research. 3(3). 263–268. 4 indexed citations
10.
Olsson, Tommy, Kjell Asplund, & E Hägg. (1990). Pituitary‐thyroid axis, prolactin and growth hormone in patients with acute stroke. Journal of Internal Medicine. 228(3). 287–290. 15 indexed citations
11.
Hägg, E, Tommy Olsson, & Kjell Grankvist. (1990). Salivary Cortisol During an Overnight Dexamethasone Suppression Test Using a Simple Saliva Collection Device. Hormone and Metabolic Research. 22(10). 553–554. 10 indexed citations
12.
Dyckner, Thomas, E Hägg, Folke Lithner, Henry Nyhlin, & P O Wester. (1989). Muscle magnesium and capillary basement membrane thickness in diabetes mellitus.. PubMed. 14(5). 619–22.
13.
Hägg, E, Kjell Asplund, & Folke Lithner. (1987). VALUE OF BASAL PLASMA CORTISOL ASSAYS IN THE ASSESSMENT OF PITUITARY‐ADRENAL INSUFFICIENCY. Clinical Endocrinology. 26(2). 221–226. 179 indexed citations
14.
Eriksson, Sture, Kjell Asplund, E Hägg, et al.. (1987). Clinical profiles of cerebrovascular disorders in a population-based patient sample. Journal of Chronic Diseases. 40(11). 1025–1032. 26 indexed citations
15.
Hägg, E, et al.. (1987). Is endocrine ophthalmopathy related to smoking?. BMJ. 295(6599). 634–635. 102 indexed citations
16.
Hägg, E, Malin Eklund, & Ove Törring. (1984). Disodium etidronate in hypercalcaemia due to immobilisation.. BMJ. 288(6417). 607.2–608. 10 indexed citations
17.
Strand, T, Kjell Asplund, Sture Eriksson, et al.. (1984). A randomized controlled trial of hemodilution therapy in acute ischemic stroke.. Stroke. 15(6). 980–989. 109 indexed citations
18.
Eriksson, Sture, Kjell Asplund, E Hägg, et al.. (1984). Pulmonary-artery cineangiocardiography to demonstrate cardiac thrombi in patients with cerebral infarction. Acta Neurologica Scandinavica. 69(1). 27–33. 14 indexed citations
19.
Asplund, Kjell, et al.. (1982). Hyperosmolar Non‐Ketotic Coma in Diabetic Stroke Patients. Acta Medica Scandinavica. 212(6). 407–411. 8 indexed citations
20.
Hägg, E, et al.. (1979). [Occurrence of diabetes mellitus in patients with cerebrovascular diseases].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 76(30-31). 2627–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026